Greenwich LifeSciences
GLSI
#8391
Rank
NZ$0.51 B
Marketcap
NZ$35.19
Share price
-2.73%
Change (1 day)
142.44%
Change (1 year)

EPS for Greenwich LifeSciences (GLSI)

EPS in 2026 (TTM): NZ-$2.13

According to Greenwich LifeSciences's latest financial reports the company's current EPS (TTM) is NZ-$2.27. In 2025 the company made an earnings per share (EPS) of NZ-$2.61 a decrease over its 2024 EPS that were of NZ-$2.45.

EPS history for Greenwich LifeSciences from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.13-18.5%
2025NZ-$2.616.72%
2024NZ-$2.4594.2%
2023NZ-$1.2613.11%
2022NZ-$1.1274.29%
2021NZ-$0.6475%
2020NZ-$0.37-30.11%
2019NZ-$0.52102.72%
2018NZ-$0.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
NZ-$21.06 829.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ-$12.98 472.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ-$2.78 22.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
NZ-$1.94-14.52% Jersey